• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

New Reforms to Prescription Drug Pricing in the US: Opportunities and Challenges.

作者信息

Hwang Thomas J, Kesselheim Aaron S, Rome Benjamin N

机构信息

Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Division of Urological Surgery, Brigham and Women's Hospital, Boston, Massachusetts.

出版信息

JAMA. 2022 Sep 20;328(11):1041-1042. doi: 10.1001/jama.2022.15268.

DOI:10.1001/jama.2022.15268
PMID:35984652
Abstract
摘要

相似文献

1
New Reforms to Prescription Drug Pricing in the US: Opportunities and Challenges.美国处方药定价的新改革：机遇与挑战。
JAMA. 2022 Sep 20;328(11):1041-1042. doi: 10.1001/jama.2022.15268.
2
Value-Based Pricing and State Reform of Prescription Drug Costs.基于价值的定价与处方药成本的国家改革。
JAMA. 2017 Aug 15;318(7):609-610. doi: 10.1001/jama.2017.8255.
3
Fair global drug pricing.公平的全球药品定价。
Expert Rev Pharmacoecon Outcomes Res. 2018 Dec;18(6):581-583. doi: 10.1080/14737167.2018.1524296. Epub 2018 Sep 28.
4
International Reference Pricing for Prescription Drugs in the United States: Administrative Limitations and Collateral Effects.美国处方药国际参考定价：行政限制与附带影响。
Value Health. 2021 Apr;24(4):473-476. doi: 10.1016/j.jval.2020.11.009. Epub 2020 Dec 31.
5
The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.美国处方药价格居高不下：根源与改革前景。
JAMA. 2016;316(8):858-71. doi: 10.1001/jama.2016.11237.
6
Physician and Patient Adjustment to Reference Pricing for Drugs.医生和患者对药品参考定价的调整。
JAMA Netw Open. 2020 Feb 5;3(2):e1920544. doi: 10.1001/jamanetworkopen.2019.20544.
7
Prescription Drug Pricing.处方药定价
Ann Emerg Med. 2018 Oct;72(4):e59. doi: 10.1016/j.annemergmed.2018.07.029.
8
Payment Reforms, Prescription Drugs, And More.支付改革、处方药等等。
Health Aff (Millwood). 2016 Sep 1;35(9):1555. doi: 10.1377/hlthaff.2016.1046.
9
Trends in Prescription Drug Spending Leading Up to Health Reform.医疗改革前处方药支出的趋势。
Med Care Res Rev. 2014 Aug;71(4):416-32. doi: 10.1177/1077558714533820. Epub 2014 May 14.
10
The impacts and unintended consequences of the nationwide pricing reform for drugs and medical services in the urban public hospitals in China.中国城市公立医院药品和医疗服务价格改革的影响及意外后果。
BMC Health Serv Res. 2020 Nov 23;20(1):1058. doi: 10.1186/s12913-020-05849-4.

引用本文的文献

1
Price determinants and pricing policies concerning potentially innovative health technologies: a scoping review.关于潜在创新型卫生技术的价格决定因素及定价政策：一项范围综述
Eur J Health Econ. 2025 Sep 6. doi: 10.1007/s10198-025-01834-y.
2
Changes in Medicare Part D Plan Designs After the Inflation Reduction Act.《降低通胀法案》出台后医疗保险D部分计划设计的变化。
JAMA Intern Med. 2025 Aug 18. doi: 10.1001/jamainternmed.2025.4003.
3
A Global Comparison of Liver Transplant Drug Pricing: US Versus Other G7 Countries and Australia.肝移植药物定价的全球比较：美国与其他七国集团国家及澳大利亚
Transplant Direct. 2025 May 12;11(6):e1805. doi: 10.1097/TXD.0000000000001805. eCollection 2025 Jun.
4
Use of real-world evidence in the Medicare Drug Price Negotiation Program: A checklist for the Centers for Medicare and Medicaid Services and manufacturers.在医疗保险药品价格谈判计划中使用真实世界证据：给医疗保险和医疗补助服务中心及制造商的一份清单。
Health Aff Sch. 2025 Mar 21;3(3):qxaf030. doi: 10.1093/haschl/qxaf030. eCollection 2025 Mar.
5
Drivers of innovation value: simulation for new drug pricing evaluation based on system dynamics modelling.创新价值驱动因素：基于系统动力学建模的新药定价评估模拟
Front Pharmacol. 2025 Jan 22;16:1474856. doi: 10.3389/fphar.2025.1474856. eCollection 2025.
6
Association of Medicare eligibility with access to and affordability of care among older cancer survivors.医疗保险资格与老年癌症幸存者获得医疗服务及医疗费用负担能力之间的关联
J Cancer Surviv. 2024 Mar 23. doi: 10.1007/s11764-024-01562-x.
7
Is the price right? Paying for value today to get more value tomorrow.价格合理吗？今天为价值买单，明天收获更多价值。
BMC Med. 2024 Jan 30;22(1):45. doi: 10.1186/s12916-024-03262-w.
8
Sociodemographic and spending characteristics of Medicare beneficiaries taking prescription drugs subject to price negotiations.接受受价格谈判约束的处方药的医疗保险受益人在社会人口统计学和支出特征方面的情况。
J Manag Care Spec Pharm. 2024 Mar 1;30(3):269-278. doi: 10.18553/jmcp.2023.23153. Epub 2023 Dec 23.
9
Stakeholder Perspectives of the Inflation Reduction Act's (2022) Impact on Prescription Drugs: A Narrative Review.利益相关者对《降低通胀法案》（2022年）对处方药影响的观点：一项叙述性综述。
Pharmacy (Basel). 2023 Dec 17;11(6):187. doi: 10.3390/pharmacy11060187.
10
Access in all areas? A round up of developments in market access and health technology assessment: part 2.全覆盖？市场准入和卫生技术评估发展综述：第 2 部分。
J Comp Eff Res. 2023 Dec;12(12):e230162. doi: 10.57264/cer-2023-0162. Epub 2023 Nov 2.